Legal & General Group PLC Seer, Inc. Transaction History

Legal & General Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.18 - $5.52 $1,778 - $4,504	-816 Reduced 14.52%	4,803 $10,000
Q2 2023 Aug 14, 2023	SELL	$3.16 - $4.96 $10,734 - $16,849	-3,397 Reduced 37.68%	5,619 $23,000
Q1 2023 May 15, 2023	SELL	$3.6 - $5.88 $29,552 - $48,268	-8,209 Reduced 47.66%	9,016 $34,000
Q3 2022 Nov 14, 2022	SELL	$7.7 - $13.31 $111,257 - $192,316	-14,449 Reduced 45.62%	17,225 $133,000
Q2 2022 Aug 22, 2022	BUY	$6.72 - $16.07 $90,666 - $216,816	13,492 Added 74.21%	31,674 $283,000
Q1 2022 May 16, 2022	BUY	$11.88 - $23.4 $760 - $1,497	64 Added 0.35%	18,182 $277,000
Q3 2021 Nov 15, 2021	BUY	$27.67 - $45.04 $356,583 - $580,430	12,887 Added 246.36%	18,118 $626,000
Q2 2021 Aug 12, 2021	BUY	$28.75 - $56.92 $107,295 - $212,425	3,732 Added 248.97%	5,231 $171,000
Q1 2021 May 17, 2021	BUY	$38.67 - $84.06 $19,683 - $42,786	509 Added 51.41%	1,499 $75,000
Q4 2020 Feb 12, 2021	BUY	$55.23 - $81.11 $54,677 - $80,298	990 New	990 $56,000

35.2M

600

Ticker SEER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,566,500
Market Cap $142M
Description
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.